AgomAb Therapeutics Ownership | Who Owns AgomAb Therapeutics?

AgomAb Therapeutics Ownership Summary

AgomAb Therapeutics is owned by 64.45% institutional investors, 5.90% insiders, and 29.66% retail investors. Federated Hermes Kaufmann R is the top mutual fund, with 1.99% of its assets in AgomAb Therapeutics shares.

AGMB Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	AgomAb Therapeutics	64.45%	5.90%	29.66%
Sector	Healthcare Stocks	35.52%	11.86%	52.62%
Industry	Biotech Stocks	35.67%	11.81%	52.52%

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	32	-	23,354,227	-	64	-	32	-	-	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Federated Hermes Kaufmann R	981.18K	1.99%	981.18K
Federated Hermes Kaufmann Growth	981.18K	1.99%	981.18K
Fidelity Growth Compy Commingled Pl S	670.23K	1.36%	926.00
Federated Hermes Kaufmann Small Cap A	615.71K	1.25%	615.71K
Federated Hermes Kaufmann Small Cap Grow	615.71K	1.25%	615.71K
Fidelity Growth Company Fund	507.88K	1.03%	-
abrdn Healthcare Investors	351.25K	0.71%	60.39K
abrdn World Healthcare	303.26K	0.62%	28.26K
abrdn Life Sciences Investors	170.46K	0.35%	28.68K
Fidelity Growth Company K6	142.27K	0.29%	-926.00

AGMB Ownership FAQ

Who Owns AgomAb Therapeutics?

AgomAb Therapeutics shareholders are primarily institutional investors at 64.45%, followed by 5.90% insiders and 29.65% retail investors. The average institutional ownership in AgomAb Therapeutics's industry, Biotech Stocks , is 35.67%, which AgomAb Therapeutics exceeds.

Does Blackrock own AgomAb Therapeutics?

BlackRock is not among the top 10 institutional shareholders of AgomAb Therapeutics.

Who is the top mutual fund holder of AgomAb Therapeutics shares?

Federated Hermes Kaufmann R is the top mutual fund holder of AgomAb Therapeutics shares, with 1.99% of its total shares outstanding invested in 981.18K AgomAb Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools